JNJ
Johnson & Johnson
NYSE · USD · Stock
$273.20
+5.63 (+2.10%)
past month
Closed- Market cap
- $657.68B
- P/E
- 41.46
- Yield
- 1.96%
- Volume
- 9M
- 52 weeks
- $185 – $282
About
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
Johnson & Johnson (JNJ) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $185.12 and $282.02, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - General
- New Brunswick, United States
- 138.2K employees
- Led by Joaquin Duato
Coming up
Ex-dividend
$1.34 per share last time
Dividend paid
To owners on the ex-dividend day
Financials
Revenue, last 12 months
$99.33B+5.90%
Earnings
Beat the estimate
3 of 4 quarters
Q4 2025
-0.11%
Q1 2026
+0.85%
Q2 2026
+1.58%
Q3 2026
+2.69%
Earnings per share, last 12 months $6.59
Analysts
22 analysts say
Buy
12-month target$279.41+2.27%
Dividends
Yield · per share, yearly
1.96%$5.36
Ownership
- Institutions
- 76.78%
- Insiders
- 0.05%
Latest insider trade Sep 2, 2026, SCHMID TIMOTHY
Prices from Yahoo Finance, may be delayed